{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-318331","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.087596+00:00","generated_at":"2026-05-16T13:15:58.850278+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SBC Medical gains >50% control of Waqoo via ¥1,900/share tender offer","bullets":["Tender offer oversubscribed: 637,817 shares tendered vs 575,000 max; SBC to purchase 575,052 shares at ¥1,900 each (total ~¥1,092.5M).","Largest shareholder Yoshiyuki Aikawa to transfer all remaining shares off-market, pushing SBC ownership above 50%.","Settlement begins December 19, 2025; SBC becomes parent company of Waqoo, a regenerative medicine R&D firm.","Acquisition enhances SBC's healthcare technology capabilities and Japanese market presence."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-318331","json":"https://secwatch.observer/filing/0001193125-25-318331.json","markdown":"https://secwatch.observer/filing/0001193125-25-318331.md","text":"https://secwatch.observer/filing/0001193125-25-318331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000119312525318331/0001193125-25-318331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000119312525318331/sbc-20251213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:15:58.850278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}